<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01546012</url>
  </required_header>
  <id_info>
    <org_study_id>LT1550-PIV-CE-10/11</org_study_id>
    <secondary_id>2012-001233-14</secondary_id>
    <nct_id>NCT01546012</nct_id>
  </id_info>
  <brief_title>Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratoires Thea</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Axial Biotech, Inc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Laboratoires Thea</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assess the patient feeling about the handiness of two different vials used to deliver both,
      unpreserved hyaluronic eye drops.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Too difficult to select patient according to the investigator
  </why_stopped>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall preference of the patient</measure>
    <time_frame>6 weeks</time_frame>
    <description>At Visit2: Week 6 +/- 1week: End of Study Visit. &quot;Overall preference of the patient&quot;: number of answers Hyabak, Hylo-comod.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops</condition>
  <arm_group>
    <arm_group_label>HYABAK®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HYLO-COMOD®:</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HYABAK®</intervention_name>
    <description>Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)</description>
    <arm_group_label>HYABAK®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HYLO-COMOD®</intervention_name>
    <description>Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)</description>
    <arm_group_label>HYLO-COMOD®:</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Man or woman aged 18 and older

          -  Patient with dry eye for at least 3 months

          -  Having given his written informed consent

        Exclusion Criteria:

          -  Intolerance to studied products

          -  Patient's inability to understand the study procedures and give informed consent.

          -  Patient unwilling to follow the study procedures and visits defined by the protocol.

          -  Pregnant or lactating women.

          -  Patient under guardian ship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carl Erb</last_name>
    <role>Principal Investigator</role>
    <affiliation>Augenklinik, Wittenbergplatz, Kleiststrasse 23-26, 10787 Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Augenklinik</name>
      <address>
        <city>Berlin</city>
        <zip>10787</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 2, 2012</study_first_submitted>
  <study_first_submitted_qc>March 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <last_update_submitted>August 31, 2015</last_update_submitted>
  <last_update_submitted_qc>August 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

